Acute and chronic phase platelet aggregability studies in Chinese patients after implantation of a permanent transvenous pacemaker
It has been suggested that the incidence of thromboembolic events always increases in patients after insertion of a transvenous pacemaker. Blood samples from twenty consecutive patients (fifteen males and five females) before and after pacemaker implantation was retained for platelet aggregability s...
Gespeichert in:
| Veröffentlicht in: | International journal of cardiology 1999-04, Vol.69 (1), p.83-86 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 86 |
|---|---|
| container_issue | 1 |
| container_start_page | 83 |
| container_title | International journal of cardiology |
| container_volume | 69 |
| creator | Kong, Chi-Woon Shih, Chun-Jo Hsiao, Hsiang-Chiang Chang, Hsin-Ya Tai, Ho-Chang Lee, Kuan-Hwa Hu, Hui-Yu Tzeng, Cheng-Hwai |
| description | It has been suggested that the incidence of thromboembolic events always increases in patients after insertion of a transvenous pacemaker. Blood samples from twenty consecutive patients (fifteen males and five females) before and after pacemaker implantation was retained for platelet aggregability studies which were analyzed separately with ADP, collagen, epinephrine and arachidonic acid. The maximal amplitude of platelet aggregatory curve was detected by an aggregometer. The samples collected the day before pacemaker implantation (day 0) were used as self-control. Day 1 and day 3 after pacemaker implantation were defined as the acute phase, while day 30 was defined as the chronic phase. The maximal amplitude of platelet aggregatory curve was observed to be lowest on day 1 and then return to normal on day 3 and day 30. The results of platelet aggregability, however, showed no significant difference (
P>0.05) between self-control and post-implantation samples. In conclusion, there was no significant change in platelet aggregability for either acute or chronic phases after pacemaker implantation. Antiplatelet medications may not be necessary for the prevention of thromboembolic events after the implantation of a pacemaker. |
| doi_str_mv | 10.1016/S0167-5273(99)00012-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69807029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167527399000121</els_id><sourcerecordid>69807029</sourcerecordid><originalsourceid>FETCH-LOGICAL-c338t-ccbf2413878e5526b76e04db013b98abcfcdf642d89e1c6c36c63184caaf9ff13</originalsourceid><addsrcrecordid>eNqFkMFu1DAQhi1ERZfCI4B8QAgOATtOYvuEqlWBSpU4AGfLmYx3DYkTbKdSr31yvN0VcOPikazvn_n1EfKCs3ec8e791_LIqq2leKP1W8YYryv-iGy4kk3FZds8Jps_yDl5mtKPAjVaqyfknDPR1ULKDbm_hDUjtWGgsI9z8ECXvU1Il9FmHDFTu9tF3Nnejz7f0ZTXwWOiPtDt3gc8kDZ7DDlR6zJG6qcSDbl8zoHOjlq6YJxsKAjN0YZ0i2FeU4kBTvYnxmfkzNkx4fPTvCDfP159236ubr58ut5e3lQghMoVQO_qhgslFbZt3fWyQ9YMPeOi18r24GBwXVMPSiOHDkQHneCqAWuddo6LC_L6uHeJ868VUzaTT4BjaYulkOm0YpLVuoDtEYQ4pxTRmSX6ycY7w5k5yDcP8s3BrNHaPMg3hwMvTwfWfsLhn9TRdgFenQCbwI6u2ACf_nJStbypC_bhiGGxcesxmgTFMODgI0I2w-z_0-Q3K5CkQg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69807029</pqid></control><display><type>article</type><title>Acute and chronic phase platelet aggregability studies in Chinese patients after implantation of a permanent transvenous pacemaker</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Kong, Chi-Woon ; Shih, Chun-Jo ; Hsiao, Hsiang-Chiang ; Chang, Hsin-Ya ; Tai, Ho-Chang ; Lee, Kuan-Hwa ; Hu, Hui-Yu ; Tzeng, Cheng-Hwai</creator><creatorcontrib>Kong, Chi-Woon ; Shih, Chun-Jo ; Hsiao, Hsiang-Chiang ; Chang, Hsin-Ya ; Tai, Ho-Chang ; Lee, Kuan-Hwa ; Hu, Hui-Yu ; Tzeng, Cheng-Hwai</creatorcontrib><description>It has been suggested that the incidence of thromboembolic events always increases in patients after insertion of a transvenous pacemaker. Blood samples from twenty consecutive patients (fifteen males and five females) before and after pacemaker implantation was retained for platelet aggregability studies which were analyzed separately with ADP, collagen, epinephrine and arachidonic acid. The maximal amplitude of platelet aggregatory curve was detected by an aggregometer. The samples collected the day before pacemaker implantation (day 0) were used as self-control. Day 1 and day 3 after pacemaker implantation were defined as the acute phase, while day 30 was defined as the chronic phase. The maximal amplitude of platelet aggregatory curve was observed to be lowest on day 1 and then return to normal on day 3 and day 30. The results of platelet aggregability, however, showed no significant difference (
P>0.05) between self-control and post-implantation samples. In conclusion, there was no significant change in platelet aggregability for either acute or chronic phases after pacemaker implantation. Antiplatelet medications may not be necessary for the prevention of thromboembolic events after the implantation of a pacemaker.</description><identifier>ISSN: 0167-5273</identifier><identifier>EISSN: 1874-1754</identifier><identifier>DOI: 10.1016/S0167-5273(99)00012-1</identifier><identifier>PMID: 10362377</identifier><identifier>CODEN: IJCDD5</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Aged ; Biological and medical sciences ; China ; Diseases of the cardiovascular system ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; Pacemaker, Artificial - adverse effects ; Platelet Aggregation - physiology ; Platelet Aggregation Inhibitors - therapeutic use ; Platelet Function Tests ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Thromboembolism - etiology ; Thromboembolism - prevention & control</subject><ispartof>International journal of cardiology, 1999-04, Vol.69 (1), p.83-86</ispartof><rights>1999 Elsevier Science Ireland Ltd</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c338t-ccbf2413878e5526b76e04db013b98abcfcdf642d89e1c6c36c63184caaf9ff13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0167527399000121$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1785142$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10362377$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kong, Chi-Woon</creatorcontrib><creatorcontrib>Shih, Chun-Jo</creatorcontrib><creatorcontrib>Hsiao, Hsiang-Chiang</creatorcontrib><creatorcontrib>Chang, Hsin-Ya</creatorcontrib><creatorcontrib>Tai, Ho-Chang</creatorcontrib><creatorcontrib>Lee, Kuan-Hwa</creatorcontrib><creatorcontrib>Hu, Hui-Yu</creatorcontrib><creatorcontrib>Tzeng, Cheng-Hwai</creatorcontrib><title>Acute and chronic phase platelet aggregability studies in Chinese patients after implantation of a permanent transvenous pacemaker</title><title>International journal of cardiology</title><addtitle>Int J Cardiol</addtitle><description>It has been suggested that the incidence of thromboembolic events always increases in patients after insertion of a transvenous pacemaker. Blood samples from twenty consecutive patients (fifteen males and five females) before and after pacemaker implantation was retained for platelet aggregability studies which were analyzed separately with ADP, collagen, epinephrine and arachidonic acid. The maximal amplitude of platelet aggregatory curve was detected by an aggregometer. The samples collected the day before pacemaker implantation (day 0) were used as self-control. Day 1 and day 3 after pacemaker implantation were defined as the acute phase, while day 30 was defined as the chronic phase. The maximal amplitude of platelet aggregatory curve was observed to be lowest on day 1 and then return to normal on day 3 and day 30. The results of platelet aggregability, however, showed no significant difference (
P>0.05) between self-control and post-implantation samples. In conclusion, there was no significant change in platelet aggregability for either acute or chronic phases after pacemaker implantation. Antiplatelet medications may not be necessary for the prevention of thromboembolic events after the implantation of a pacemaker.</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>China</subject><subject>Diseases of the cardiovascular system</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pacemaker, Artificial - adverse effects</subject><subject>Platelet Aggregation - physiology</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Platelet Function Tests</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Thromboembolism - etiology</subject><subject>Thromboembolism - prevention & control</subject><issn>0167-5273</issn><issn>1874-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMFu1DAQhi1ERZfCI4B8QAgOATtOYvuEqlWBSpU4AGfLmYx3DYkTbKdSr31yvN0VcOPikazvn_n1EfKCs3ec8e791_LIqq2leKP1W8YYryv-iGy4kk3FZds8Jps_yDl5mtKPAjVaqyfknDPR1ULKDbm_hDUjtWGgsI9z8ECXvU1Il9FmHDFTu9tF3Nnejz7f0ZTXwWOiPtDt3gc8kDZ7DDlR6zJG6qcSDbl8zoHOjlq6YJxsKAjN0YZ0i2FeU4kBTvYnxmfkzNkx4fPTvCDfP159236ubr58ut5e3lQghMoVQO_qhgslFbZt3fWyQ9YMPeOi18r24GBwXVMPSiOHDkQHneCqAWuddo6LC_L6uHeJ868VUzaTT4BjaYulkOm0YpLVuoDtEYQ4pxTRmSX6ycY7w5k5yDcP8s3BrNHaPMg3hwMvTwfWfsLhn9TRdgFenQCbwI6u2ACf_nJStbypC_bhiGGxcesxmgTFMODgI0I2w-z_0-Q3K5CkQg</recordid><startdate>19990430</startdate><enddate>19990430</enddate><creator>Kong, Chi-Woon</creator><creator>Shih, Chun-Jo</creator><creator>Hsiao, Hsiang-Chiang</creator><creator>Chang, Hsin-Ya</creator><creator>Tai, Ho-Chang</creator><creator>Lee, Kuan-Hwa</creator><creator>Hu, Hui-Yu</creator><creator>Tzeng, Cheng-Hwai</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990430</creationdate><title>Acute and chronic phase platelet aggregability studies in Chinese patients after implantation of a permanent transvenous pacemaker</title><author>Kong, Chi-Woon ; Shih, Chun-Jo ; Hsiao, Hsiang-Chiang ; Chang, Hsin-Ya ; Tai, Ho-Chang ; Lee, Kuan-Hwa ; Hu, Hui-Yu ; Tzeng, Cheng-Hwai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c338t-ccbf2413878e5526b76e04db013b98abcfcdf642d89e1c6c36c63184caaf9ff13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>China</topic><topic>Diseases of the cardiovascular system</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pacemaker, Artificial - adverse effects</topic><topic>Platelet Aggregation - physiology</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Platelet Function Tests</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Thromboembolism - etiology</topic><topic>Thromboembolism - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kong, Chi-Woon</creatorcontrib><creatorcontrib>Shih, Chun-Jo</creatorcontrib><creatorcontrib>Hsiao, Hsiang-Chiang</creatorcontrib><creatorcontrib>Chang, Hsin-Ya</creatorcontrib><creatorcontrib>Tai, Ho-Chang</creatorcontrib><creatorcontrib>Lee, Kuan-Hwa</creatorcontrib><creatorcontrib>Hu, Hui-Yu</creatorcontrib><creatorcontrib>Tzeng, Cheng-Hwai</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kong, Chi-Woon</au><au>Shih, Chun-Jo</au><au>Hsiao, Hsiang-Chiang</au><au>Chang, Hsin-Ya</au><au>Tai, Ho-Chang</au><au>Lee, Kuan-Hwa</au><au>Hu, Hui-Yu</au><au>Tzeng, Cheng-Hwai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute and chronic phase platelet aggregability studies in Chinese patients after implantation of a permanent transvenous pacemaker</atitle><jtitle>International journal of cardiology</jtitle><addtitle>Int J Cardiol</addtitle><date>1999-04-30</date><risdate>1999</risdate><volume>69</volume><issue>1</issue><spage>83</spage><epage>86</epage><pages>83-86</pages><issn>0167-5273</issn><eissn>1874-1754</eissn><coden>IJCDD5</coden><abstract>It has been suggested that the incidence of thromboembolic events always increases in patients after insertion of a transvenous pacemaker. Blood samples from twenty consecutive patients (fifteen males and five females) before and after pacemaker implantation was retained for platelet aggregability studies which were analyzed separately with ADP, collagen, epinephrine and arachidonic acid. The maximal amplitude of platelet aggregatory curve was detected by an aggregometer. The samples collected the day before pacemaker implantation (day 0) were used as self-control. Day 1 and day 3 after pacemaker implantation were defined as the acute phase, while day 30 was defined as the chronic phase. The maximal amplitude of platelet aggregatory curve was observed to be lowest on day 1 and then return to normal on day 3 and day 30. The results of platelet aggregability, however, showed no significant difference (
P>0.05) between self-control and post-implantation samples. In conclusion, there was no significant change in platelet aggregability for either acute or chronic phases after pacemaker implantation. Antiplatelet medications may not be necessary for the prevention of thromboembolic events after the implantation of a pacemaker.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>10362377</pmid><doi>10.1016/S0167-5273(99)00012-1</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-5273 |
| ispartof | International journal of cardiology, 1999-04, Vol.69 (1), p.83-86 |
| issn | 0167-5273 1874-1754 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69807029 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Aged Biological and medical sciences China Diseases of the cardiovascular system Female Humans Male Medical sciences Middle Aged Pacemaker, Artificial - adverse effects Platelet Aggregation - physiology Platelet Aggregation Inhibitors - therapeutic use Platelet Function Tests Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Thromboembolism - etiology Thromboembolism - prevention & control |
| title | Acute and chronic phase platelet aggregability studies in Chinese patients after implantation of a permanent transvenous pacemaker |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T05%3A39%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20and%20chronic%20phase%20platelet%20aggregability%20studies%20in%20Chinese%20patients%20after%20implantation%20of%20a%20permanent%20transvenous%20pacemaker&rft.jtitle=International%20journal%20of%20cardiology&rft.au=Kong,%20Chi-Woon&rft.date=1999-04-30&rft.volume=69&rft.issue=1&rft.spage=83&rft.epage=86&rft.pages=83-86&rft.issn=0167-5273&rft.eissn=1874-1754&rft.coden=IJCDD5&rft_id=info:doi/10.1016/S0167-5273(99)00012-1&rft_dat=%3Cproquest_cross%3E69807029%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69807029&rft_id=info:pmid/10362377&rft_els_id=S0167527399000121&rfr_iscdi=true |